Dartmouth-Hitchcock Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).
Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.
Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.
Top-decile sponsor footprint
Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
427 total, page 1 of 9
Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet
NCT07223255
Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
NCT07428629
TF-CBT for Autistic Youth Pilot Implementation - Open Pilot
NCT07420478
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
NCT07195513
ABY-029 Glioma Trial
NCT07063693
Nutrition to Support Postoperative Recovery
NCT07109505
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
NCT07201376
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
NCT06930846
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
NCT07071038
Efficacy of the I-CARE Digital Health Intervention
NCT07150832
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
NCT07043270
HOBSCOTCH-MS-Efficacy Trial
NCT06951919
Testing a Mammography Decision Intervention in a Rural Setting
NCT06522568
Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research
NCT06838689
Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease
NCT06952933
Self-discontinuation of Urinary Catheters in a Rural Population
NCT07041151
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
NCT06425029
24GUT540 : Meeting of Breast Cancer Patients and Pathologists
NCT07040514
Study of ICG Fluorescence Imaging in Open Fracture and Infection Patients
NCT06793644
TRAIL Study: Feasibility and Pilot
NCT06220656
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
NCT06898593
Bioimpedance for Ortho Trauma
NCT06858488
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
NCT06134375
Comparison of Compounded Topical Anesthetics
NCT06569537
Harm Reduction for Smokers With Mental Illness
NCT06543407
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
NCT05933395
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
NCT06330545
Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)
NCT05302375
MCI Speech in Noise
NCT06102486
D20054;LITT for Spine Tumors
NCT06548061
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
NCT06258993
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
NCT05405413
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
NCT05955339
Pulse-Width Modulation
NCT06120231
The Effect of Clinic Visit Audio Recordings for Self-management in Older Adults
NCT05824572
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
NCT05956158
Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
NCT05982795
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
NCT05107466
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NCT05780684
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT05612347
Healthy Homes Study
NCT05833334
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
NCT05716516
OCT in Open Fracture and Infected Fracture
NCT05785182
Gastric US in ICU Patient
NCT05526105
Human Intracranial Electrophysiology
NCT05529264
Immune Profiling for Cancer Immunotherapy Response
NCT06116032
Evaluation of the CONVIVO System
NCT05139277
Utility of CC7 Transfer in Stroke Subtypes
NCT06001736
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
NCT04678895
Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)
NCT04458584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 44 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Dartmouth-Hitchcock Medical Center pipeline
52 recruiting of 427 indexed (12% open); 300 completed (70%).
Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide
Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 427 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Friends Research Institute · 12% recruiting · 41 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this Dartmouth-Hitchcock Medical Center page
427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.
- 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets.Report a data error.